Systematic construction and validation of an immune prognostic model for lung adenocarcinoma

Clicks: 166
ID: 111606
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Lung adenocarcinoma (LUAD), the most common non-small-cell lung cancer, is characterized by a dense lymphocytic infiltrate, which indicates that the immune system plays an active role in the development and growth of this cancer. However, no investigations to date have proposed robust models for pre ā€¦
Reference Key
c2020journalsystematic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Luo C;Lei M;Zhang Y;Zhang Q;Li L;Lian J;Liu S;Wang L;Pi G;Zhang Y;;
Journal Journal of cellular and molecular medicine
Year 2020
DOI DOI not found
URL
https://www.pubmed.gov/31779055/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:31779055 pmc6991688 doi:10.1111/jcmm.14719 chenghan luo mengyuan lei yi zhang

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.